NASDAQ: IBRX
Immunitybio Inc Earnings Dates, Reports, Calls

Immunitybio earnings were -$587.8M for the trailing 12 months ending Sep 30, 2024, with N/A growth year over year. The latest IBRX earnings report on Sep 30, 2024 announced Q3 2024 earnings of -$85.7M, down 36.3% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, IBRX reported annual earnings of -$583.2M, with 40% growth. The next IBRX earnings date is Mar 17, 2025.

IBRX earnings history

Current Revenue
$7.3M
Current Earnings
-$587.8M
Current Profit Margin
-8,016.8%

IBRX Return on Equity

Insufficient data to display

IBRX Return on Assets

Current Company
-137.2%
Current Industry
1.3%
IBRX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when IBRX announces earnings.

IBRX Return on Capital Employed

Current Company
-144.58%
Current Industry
14.3%
IBRX has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

IBRX vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
IBRX-$415.51M-$587.79MN/A-$0.90
APGE-$145.53M-$146.66MN/A-$2.42
PTGX$176.27M$170.85MN/A$2.89
VERA-$126.64M-$134.38MN/A-$2.61
BEAM-$120.34M-$143.59MN/A-$1.58

IBRX earnings dates

Next earnings date
Mar 17, 2025

Immunitybio Earnings Reports & History FAQ

What were Immunitybio's earnings last quarter?

On IBRX's earnings call on Invalid Date, Immunitybio (NASDAQ: IBRX) reported Q3 2024 earnings per share (EPS) of -$0.12, up 36.84% year over year. Total IBRX earnings for the quarter were -$85.73 million. In the same quarter last year, Immunitybio's earnings per share (EPS) was -$0.19.

If you're new to stock investing, here's how to buy Immunitybio stock.

When does Immunitybio report earnings?

The next IBRX earnings date is Invalid Date. Add IBRX to your watchlist to be reminded of Immunitybio's next earnings date.

What was IBRX's earnings growth in the past year?

As of Immunitybio's earnings date in Invalid Date, Immunitybio's earnings has grown year over year. IBRX earnings in the past year totalled -$587.79 million.

Is Immunitybio profitable or losing money?

As of the last Immunitybio earnings report, Immunitybio is currently losing money. Immunitybio's net profit (also called net income) for the twelve months ending Sep 30, 2024 was -$587.79 million, a 28.33% increase year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.